• Explore /
  • Poster
  • / Activity of new agents (NAs) as third-line treatment in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) showing a primary resistance (PRes) to NAs-based second line therapy after docetaxel (DOC): Preliminary results from a multicenter Italian study.

Activity of new agents (NAs) as third-line treatment in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) showing a primary resistance (PRes) to NAs-based second line therapy after docetaxel (DOC): Preliminary results from a multicenter Italian study.

Abstract Poster

Authors

null

Orazio Caffo

Santa Chiara Hospital, Trento, Italy

Orazio Caffo , Ugo De Giorgi , Gaetano Facchini , Lucia Fratino , Donatello Gasparro , Umberto Basso , Daniele Alesini , Marcello Tucci , Cinzia Ortega , Francesco Verderame , Giuseppe Procopio , Giovanni Lo Re , Enrico Campadelli , Claudia Omarini , Maddalena Donini , Franco Morelli , Paolo A. Zucali , Donata Sartori , Vincenza Conteduca , Enzo Galligioni

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 33, 2015 (suppl 7; abstr 216)

DOI

10.1200/jco.2015.33.7_suppl.216

Abstract #

216

Poster Bd #

B9

Abstract Disclosures

Similar Posters

First Author: Orazio Caffo

First Author: Celestia S. Higano

First Author: Orazio Caffo

First Author: Orazio Caffo